Palo Alto Investors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-10,137
| Closed | -$5K | – | 39 |
|
|
2019
Q4 | $5K | Hold |
10,137
| – | – | ﹤0.01% | 37 |
|
|
2019
Q3 | $39K | Hold |
10,137
| – | – | ﹤0.01% | 37 |
|
|
2019
Q2 | $67K | Hold |
10,137
| – | – | ﹤0.01% | 38 |
|
|
2019
Q1 | $36K | Sell |
10,137
-1
| -0% | -$4 | ﹤0.01% | 36 |
|
|
2018
Q4 | $40K | Hold |
10,138
| – | – | ﹤0.01% | 35 |
|
|
2018
Q3 | $200K | Hold |
10,138
| – | – | 0.01% | 35 |
|
|
2018
Q2 | $322K | Hold |
10,138
| – | – | 0.01% | 36 |
|
|
2018
Q1 | $375K | Hold |
10,138
| – | – | 0.02% | 36 |
|
|
2017
Q4 | $801K | Buy |
+10,138
| New | +$801K | 0.03% | 34 |
|